Procalcitonina - Diagnostic Marker in Neonatal Sepsis

Milulescu, Amelia; Dorneanu, Florin; Iacob, Daniela; Stoian, Dana; Petre, Ion; Chiriac, Veronica Daniela; Margan, Roxana; Ioniță, Ioana; Marti, Daniela; Moleriu, Lavinia Cristina

doi:10.37358/mp.17.4.4937

Cited by 2 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another main problem could be the fact that the patient may have cardiovascular diseases, thrombophilia kidney diseases, [10,11] and hepatic disease in her heredocolaterale antecedents. Some of our patients, who are registered at the Bega Hospital in the Obstetrics and Gynecologic section have in the family chronic kidney failure and their first degree relatives are going on a dialysis program [12].…”

Section: Resultsmentioning

confidence: 99%

The Use of Pulse Wave Velocity in Predicting Pre-Eclampsia in High-Risk Women

Ivan¹,

Petre²,

Vlaicu³

et al. 2018

Rev. Chim.

Self Cite

View full text Add to dashboard Cite

In this study, we evaluated the diagnostic utility of pulls wave velocity (PWV) alone or in combination with other diagnostic markers in predicting pre-eclampsia (PE) on high-risk women. Pregnant women at high risk for PE were recruited between 32 and 36 weeks of gestation period. This study is the first in Romanian and shows that PWV may be a potentially promising predictor of early-onset PE in women at high risk for PE. All these patients were treated and were instructed according to the ESC/ESH guidelines regarding hypertensive patients. Statistical analysis was performed using the Chi-square, a Mann-Whitney test, Pearson correlation, and linear regression tests.After we ran several test the main conclusions are that there is a positive correlation between the para-clinics data (creatinine, Esbach proteinuria) and the pulls wave velocity for aorta (PWVao). The risk for preeclampsia is increasing if the body mass index (BMI) of the patients is higher than the average value (BMI]26) or if the patient is a smoker.

show abstract

Section: Resultsmentioning

confidence: 99%

The Use of Pulse Wave Velocity in Predicting Pre-Eclampsia in High-Risk Women

Ivan¹,

Petre²,

Vlaicu³

et al. 2018

Rev. Chim.

Self Cite

View full text Add to dashboard Cite

show abstract

“…The level of procalcitonin reflects the degree of systemic inflammatory response [20][21][22][23][24].…”

mentioning

confidence: 99%

Procalcitonin as a Marker of the Systemic Inflammatory Response to Infection on Newborn and Children (up to 1 year)

Ilyes¹,

Mladin²,

Craina³

et al. 2019

Rev. Chim.

Self Cite

View full text Add to dashboard Cite

In the last years, procalcitonin (PCT) has been proposed as an early marker of infections in newborns having registered different results. In this study, we aimed to investigate the value of serum procalcitonin for the diagnosis of sepsis in neonates and children procalcitonin in the diagnosis of neonatal sepsis and in children up to 1 year in the pathology of therespiratory system, gastrointestinal pathology, etc. At first, we established the clinical and paraclinical signs of systemic inflammation: increasing the temperature of the system, tachycardia, laboratory test: leukocytosis, C-reactive protein - for the diagnosis of sepsis.Some studies show that PCT gave a sensitivity between 83-100% and a specificity between 70-100% in early diagnosis of neonatal sepsis [1-7]; other researches question the accuracy of PCT in detecting neonatal sepsis.Procalcitonin (PCT) has been proposed as a marker of bacterial sepsis in critically ill patients. PCT is a precursor of calcitonin and a 116 amino acids protein. PCT levels more than 0.5 mg/dl are useful to determine the type of infectious process (bacterial or not).

show abstract

Procalcitonina - Diagnostic Marker in Neonatal Sepsis

Cited by 2 publications

References 3 publications

The Use of Pulse Wave Velocity in Predicting Pre-Eclampsia in High-Risk Women

The Use of Pulse Wave Velocity in Predicting Pre-Eclampsia in High-Risk Women

Procalcitonin as a Marker of the Systemic Inflammatory Response to Infection on Newborn and Children (up to 1 year)

Contact Info

Product

Resources

About